Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. EPS 2020–2025
Vaxcyte, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Vaxcyte, Inc. eps for the quarter ending March 31, 2026 was $2.30, a 121.15% increase year-over-year.
- Vaxcyte, Inc. annual eps for 2025 was $5.63, a 48.16% increase from 2024.
- Vaxcyte, Inc. annual eps for 2024 was $3.80, a 8.21% decrease from 2023.
- Vaxcyte, Inc. annual eps for 2023 was $4.14, a 20.35% increase from 2022.
- Vaxcyte, Inc. annual eps for 2022 was $3.44.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Vaxcyte, Inc. EPS — FAQ
Vaxcyte, Inc. (PCVX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Vaxcyte, Inc.'s eps?
Vaxcyte, Inc. (PCVX) reported eps of $-5.63 for fiscal 2025.
Where can I see PCVX's eps history?
The chart and table above show Vaxcyte, Inc.'s eps by year and by quarter, including the growth rate.